Loading...
ROCO
1780
Market cap73mUSD
Jul 09, Last price  
24.70TWD
1D
0.00%
1Q
-7.49%
Jan 2017
33.51%
IPO
58.64%
Name

Allied Biotech Corp

Chart & Performance

D1W1MN
ROCO:1780 chart
P/E
18.20
P/S
2.77
EPS
1.36
Div Yield, %
4.05%
Shrs. gr., 5y
0.22%
Rev. gr., 5y
6.57%
Revenues
850m
+5.28%
283,127,000359,518,000389,939,000429,026,000421,467,000478,907,000479,575,000474,465,000524,107,000573,625,000681,730,000765,264,000639,395,000618,066,000676,757,000716,746,000720,431,000806,917,000849,507,000
Net income
129m
+28.25%
-44,010,0002,699,0004,061,00064,00015,294,00039,607,0006,360,0007,014,00046,337,00040,234,00071,034,000133,481,000106,900,00079,472,00013,042,000146,741,00097,412,000100,939,000129,456,000
CFO
217m
-2.98%
059,480,00072,428,000164,274,000137,617,000223,793,000217,129,000
Dividend
Jul 17, 20251 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Allied Biotech Corporation operates as a global producer and supplier specializing in carotenoids. The company's diverse product portfolio features key carotenoids such as: Beta-Carotene, known for imparting vibrant yellow to reddish-orange hues across numerous applications. Beta-Apo-8'-Carotenal, a versatile food colorant delivering shades from rich orange to deep red. Lycopene, a valuable nutrient that provides striking red tones for incorporation into food, dietary supplements, and pharmaceutical formulations. Canthaxanthin, which contributes reddish-orange colors specifically to food and beverage products. Lutein, another carotenoid frequently derived from or associated with green leafy vegetables (like spinach, kale, and broccoli) and egg yolks. Additionally, Allied Biotech offers Nano Coenzyme Q10, an antioxidant crucial for cellular energy production. The corporation caters to a diverse clientele across the food, beverage, dietary supplement, and animal feed sectors. Established in 2001, Allied Biotech Corporation maintains its headquarters in Taipei, Taiwan.
IPO date
Apr 29, 2010
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT